ArticleFrontiers in immunology2023

A third (booster) dose of the inactivated SARS-CoV-2 vaccine elicits immunogenicity and T follicular helper cell responses in people living with HIV.

Zhengchao Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.